TOKYO, March 21, 2025 – FUJIFILM Holdings Corporation is pleased to announce that 26 products across a diverse range of business fields have been honored with the “iF Design Award 2025,” sponsored by the iF International Forum Design based in Hannover, Germany. The awarded items include the X series of mirrorless digital cameras, the instax™ series of instant cameras, medical equipment, and multifunction printers Notably, 21 of these products are from FUJIFILM Corporation, marking the fifth consecutive year that FUJIFILM Corporation has received the award for more than 20 products.
The iF Design Award is a prestigious international design award launched in 1953, and is considered one of the top three global design awards, alongside “Red Dot Design Award” in Germany and “International Design Excellence Awards (IDEA)” in the United States.
In developing all of its products and services, Fujifilm not only pursues functionality and performance, but also engages in design development that leverages superior functionality and performance. The company will continue to work on creating designs that not only have beautiful appearance but also reflect commitment to offering portability and operability for ease of use and comfort, thereby creating new product values.
- * instax is registered trademarks or trademarks of FUJIFILM Corporation.

“iF Design Award 2025” logo


















- * Available products vary by region.

- * Available products vary by region.

- * Available products vary by region.


- * Not for sale

Contact
FUJIFILM Holdings Corporation
Design Strategy Office
E-mail : dgi-101-FH-DSO@fujifilm.com
- * Please note that the contents including the product availability, specification, prices and contacts in this website are current as of the date of the press announcement and may be subject to change without prior notice.
- * This news release is issued by FUJIFILM Holdings Corporation in Japan. Fujifilm makes no representation that products on this news release are commercially available in all countries and regions including the US and EU. Approved uses of healthcare products vary by country and region.